Complement and the central nervous system: Emerging roles in development, protection and regeneration

Immunology and Cell Biology

Volumn 88, Issue 8, 2010, Pages 781-786

  Rutkowski, Martin J ^a   Sughrue, Michael E ^a   Kane, Ari J ^a   Mills, Steven A ^a   Fang, Shanna ^a   Parsa, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CNS; complement; development; proliferation; protection; regeneration

Indexed keywords

COMPLEMENT;

APOPTOSIS; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; COMPLEMENT SYSTEM; GLIA CELL; HUMAN; IMMUNITY; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; REVIEW; SYNAPTOGENESIS; TISSUE INJURY; TISSUE REGENERATION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; COMPLEMENT SYSTEM PROTEINS; CYTOPROTECTION; HUMANS; NEUROGENESIS; NEUROGLIA; NEURONS; RECEPTORS, COMPLEMENT; REGENERATION;

PROTEA;

EID: 78649330001     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.48     Document Type: Review

References (69)

1. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171: 715-727.
2. Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
3. Walport MJ. Complement. Second of two parts. N Engl J Med 2001; 344: 1140-1144.
4. Andrades JA, Nimni ME, Becerra J, Eisenstein R, Davis M, Sorgente N. Complement proteins are present in developing endochondral bone and may mediate cartilage cell death and vascularization. Exp Cell Res 1996; 227: 208-213.
5. Sakiyama H, Inaba N, Toyoguchi T, Okada Y, Matsumoto M, Moriya H et al. Immuno-localization of complement C1s and matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur. Cell Tissue Res 1994; 277: 239-245.
6. Sato T, Abe E, Jin CH, Hong MH, Katagiri T, Kinoshita T et al. The biological roles of the third component of complement in osteoclast formation. Endocrinology 1993; 133: 397-404.
7. Sato T, Hong MH, Jin CH, Ishimi Y, Udagawa N, Shinki T et al. The specific production of the third component of complement by osteoblastic cells treated with 1 alpha,25-dihydroxyvitamin D3. FEBS Lett 1991; 285: 21-24.
8. Toyoguchi T, Yamaguchi K, Nakagawa K, Fukusawa T, Moriya H, Sakiyama H. Change of complement C1s synthesis during development of hamster cartilage. Cell Tissue Res 1996; 285: 199-204.
9. Bora PS, Sohn JH, Cruz JM, Jha P, Nishihori H, Wang Y et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 2005; 174: 491-497.
10. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 2006; 103: 2328-2333.
11. Petrenko O, Beavis A, Klaine M, Kittappa R, Godin I, Lemischka IR. The molecular characterization of the fetal stem cell marker AA4. Immunity 1999; 10: 691-700.
12. Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silberstein LE. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol 2005; 175: 3698-3706.
13. Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004; 18: 1482-1490.
14. Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003; 101: 3784-3793.
15. Del Rio-Tsonis K, Tsonis PA, Zarkadis IK, Tsagas AG, Lambris JD. Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. J Immunol 1998; 161: 6819-6824.
16. Kimura Y, Madhavan M, Call MK, Santiago W, Tsonis PA, Lambris JD et al. Expression of complement 3 and complement 5 in newt limb and lens regeneration. J Immunol 2003; 170: 2331-2339.
17. Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N et al. The regulation of liver cell survival by complement. J Immunol 2009; 182: 5412-5418.
18. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 2001; 166: 2479-2486.
19. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198: 913-923.
20. D'Ambrosio AL, Pinsky DJ, Connolly ES. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med 2001; 7: 367-382.
21. Francis K, van Beek J, Canova C, Neal JW, Gasque P. Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med 2003; 5: 1-19.
22. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007; 82: 95-111.
23. Levi-Strauss M, Mallat M. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol 1987; 139: 2361-2366.
24. Morgan BP, Gasque P. Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 1997; 107: 1-7.
25. Gasque P, Fontaine M, Morgan BP. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 1995; 154: 4726-4733.
26. Cole DS, Morgan BP. Beyond lysis: how complement influences cell fate. Clin Sci (London) 2003; 104: 455-466.
27. Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 1999; 26: 201-211.
28. Nataf S, Levison SW, Barnum SR. Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage. Brain Res 2001; 894: 321-326.
29. Nataf S, Stahel PF, Davoust N, Barnum SR. Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci 1999; 22: 397-402.
30. Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 1996; 271: 20231-20234.
31. O'Barr SA, Caguioa J, Gruol D, Perkins G, Ember JA, Hugli T et al. Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol 2001; 166: 4154-4162.
32. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK et al. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 2006; 25: 1364-1374.
33. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002; 22: 629-634.
34. Shinjyo N, Stahlberg A, Dragunow M, Pekny M, Pekna M. Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 2009; 27: 2824-2832.
35. Bogestal YR, Barnum SR, Smith PL, Mattisson V, Pekny M, Pekna M. Signaling through C5aR is not involved in basal neurogenesis. J Neurosci Res 2007; 85: 2892-2897.
36. Benard M, Gonzalez BJ, Schouft MT, Falluel-Morel A, Vaudry D, Chan P et al. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J Biol Chem 2004; 279: 43487-43496.
37. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14: 453-501.
38. Benard M, Raoult E, Vaudry D, Leprince J, Falluel-Morel A, Gonzalez BJ et al. Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum. Mol Immunol 2008; 45: 3767-3774.
39. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131: 1164-1178.
40. Perry VH, O'Connor V. C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci 2008; 9: 807-811.
41. Hooks BM, Chen C. Distinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse. Neuron 2006; 52: 281-291.
42. Rus H, Cudrici C, David S, Niculescu F. The complement system in central nervous system diseases. Autoimmunity 2006; 39: 395-402.
43. Pasinetti GM, Tocco G, Sakhi S, Musleh WD, DeSimoni MG, Mascarucci P et al. Hereditary deficiencies in complement C5 are associated with intensified neurodegen-erative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis 1996; 3: 197-204.
44. Osaka H, Mukherjee P, Aisen PS, Pasinetti GM. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 1999; 73: 303-311.
45. Mukherjee P, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 2001; 77: 43-49.
46. Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroin-flammation 2008; 5: 5.
47. Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS et al. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 5702-5706.
48. Cudrici C, Ito T, Zafranskaia E, Weerth S, Rus V, Chen H et al. Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis. J Neuroimmunol 2008; 203: 94-103.
49. Chesik D, Wilczak N, De Keyser J. The insulin-like growth factor system in multiple sclerosis. Int Rev Neurobiol 2007; 79: 203-226.
50. Kuhl NM, De Keyser J, De Vries H, Hoekstra D. Insulin-like growth factor binding proteins-1 and-2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J Neurosci Res 2002; 69: 207-216.
51. van Beek J, Nicole O, Ali C, Ischenko A, MacKenzie ET, Buisson A et al. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 2001; 12: 289-293.
52. Hila S, Soane L, Koski CL. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD. Glia 2001; 36: 58-67.
53. Soane L, Rus H, Niculescu F, Shin ML. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. J Immunol 1999; 163: 6132-6138.
54. Cudrici C, Niculescu F, Jensen T, Zafranskaia E, Fosbrink M, Rus V et al. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. J Immunol 2006; 176: 3173-3180.
55. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 2001; 167: 2305-2311.
56. Rus H, Cudrici C, Niculescu F, Shin ML. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection. J Neuroimmunol 2006; 180: 9-16.
57. Zwaka TP, Torzewski J, Hoeflich A, Dejosez M, Kaiser S, Hombach V et al. The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop. FA S E B J 2003; 17: 1346-1348.
58. van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 2003; 992: 56-71.
59. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 2006; 99: 209-217.
60. Rus HG, Niculescu FI, Shin ML. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 2001; 180: 49-55.
61. Rus HG, Niculescu F, Shin ML. Sublytic complement attack induces cell cycle in oligodendrocytes. J Immunol 1996; 156: 4892-4900.
62. Fosbrink M, Niculescu F, Rus H. The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res 2005; 31: 37-46.
63. Ludwin SK. Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature 1984; 308: 274-275.
64. Weerth SH, Rus H, Shin ML, Raine CS. Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am J Pathol 2003; 163: 1069-1080.
65. Ramaglia V, Daha MR, Baas F. The complement system in the peripheral nerve: friend or foe? Mol Immunol 2008; 45: 3865-3877.
66. Jauneau AC, Ischenko A, Chatagner A, Benard M, Chan P, Schouft MT et al. Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes. J Neuroinflammation 2006; 3: 8.
67. Barde YA. Trophic factors and neuronal survival. Neuron 1989; 2: 1525-1534.
68. Oderfeld-Nowak B, Bacia A, Gradkowska M, Fusco M, Vantini G, Leon A et al. In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules. Neurochem Int 1992; 21: 455-461.
69. Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998; 70: 699-707.